FC
BSX icon

Financial Consulate’s Boston Scientific BSX Stock Holding History

Financial Consulate’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2K Sell
28
-260
-90% -$14.1K ﹤0.01% 1133
2026
Q1 		$18.1K Hold
288
– – ﹤0.01% 507
2025
Q4 		$27.5K Buy
288
+28
+11% +$2.75K ﹤0.01% 423
2025
Q3 		$25.4K Buy
+260
New +$26.9K ﹤0.01% 411

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Financial Consulate's BSX Position: Q2 2026 in Review

Financial Consulate reduced its Boston Scientific (BSX) stake by 90% in Q2 2026, selling an estimated $14.1K and leaving 28 shares worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1133.

Financial Consulate first reported a position in BSX in Q3 2025 and has held it in 4 quarters since. The position peaked at $27.5K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Financial Consulate held 28 shares of Boston Scientific worth $1.2K as of Q2 2026.
  • Financial Consulate sold 260 Boston Scientific shares in Q2 2026, an estimated $14.1K.
  • Boston Scientific made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #1133 holding.
  • Financial Consulate first reported a position in Boston Scientific in Q3 2025 and has held it in 4 quarters since.
  • Financial Consulate's Boston Scientific position peaked at $27.5K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.